Study of the Safety and Efficacy of RVL-1201 in the Treatment of Acquired Blepharoptosis
Clinical trial NCT02436759 · COMPLETED
Trial details
- NCT number
- NCT02436759
- Sponsor
- RVL Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-11-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.